Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

Potential drug interactions and duplicate prescriptions among cancer patients.

Riechelmann RP, Tannock IF, Wang L, et al. Potential drug interactions and duplicate prescriptions among cancer patients. J Natl Cancer Inst. 2007;99(8):592-600.

Save
Print
May 2, 2007
Riechelmann RP, Tannock IF, Wang L, et al. J Natl Cancer Inst. 2007;99(8):592-600.
View more articles from the same authors.

Medication safety efforts continue to focus on minimizing drug interactions. Furthermore, an aging population and greater use of chronic medications may increase the risk of such events. This study surveyed more than 400 cancer patients and discovered that more than 25% of them were at risk for a potential drug interaction. Most cases involved non-cancer agents such as warfarin and antihypertensives. In a small number of cases, patients received duplicate prescriptions. While the authors discuss the role of clinical decision support systems in preventing these events, their findings noted only potential drug interactions and not true adverse events. A similar study reported on potential drug interactions in hospitalized cancer patients.

Save
Print
Cite
Citation

Riechelmann RP, Tannock IF, Wang L, et al. Potential drug interactions and duplicate prescriptions among cancer patients. J Natl Cancer Inst. 2007;99(8):592-600.

Related Resources From the Same Author(s)
Related Resources